Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.251
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.291
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.521
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.663
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.768
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lipase
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lipase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.872
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:131m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:154m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0645
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.112
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.406
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Creatinine
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0256
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.292
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.891
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0103
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0791
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.990
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.360
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.532
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00558
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.259
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.519
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
6.48×10-08
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.512
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.623
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.209
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.988
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.171
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.491
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.763
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0274
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.839
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.883
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
7.89×10-05
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.620
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
2.16×10-05
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.134
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.638
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.832
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.977
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0218
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.107
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.167
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.162
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.255
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.685
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
5.12×10-05
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.299
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.300
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:154m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:131m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.196
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.469
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.939
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
4.40×10-05
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0234
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.370
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0290
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.224
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.238
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0488
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.165
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.544
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.446
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.642
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.905
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / UIBC (unsaturated iron binding capacity)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / UIBC (unsaturated iron binding capacity)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.312
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00523
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.132
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.889
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.322
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.412
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Insulin Blood Level / Insulin
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Insulin Blood Level / Insulin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.107
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.183
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.190
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00165
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0976
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.441
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
5f:15m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:30m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00106
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0916
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.620
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total bilirubin
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00281
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00878
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.487
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.200
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.545
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.919
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.000611
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.471
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.738
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.819
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:131m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:154m
|
|
|
NotProcessed |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglycerides
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0848
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.108
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.156
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.149
|
Successful |
Slc20a2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.516
|
Successful |
Slc20a2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.772
|
Successful |